Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Liothyronine (Primary) ; Cyanocobalamin
- Indications Atrial fibrillation
- Focus Therapeutic Use
Most Recent Events
- 24 Jul 2012 Biomarkers information updated
- 23 Jul 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 22 Sep 2011 Planned End Date changed from 1 Apr 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.